Skip to main content
Category

Research Articles

Jan 04

24. Enzymatic Stability, Solution Structure, and Antiproliferative Effect on Prostate Cancer Cells of Leuprolide and New GnRH Peptide Analogs

24. E.V. Pappa, A.A. Zompra, Z. Spyranti, Z. Diamantopoulou, G. Pairas, F.N. Lamari, P. Katsoris, G.A. Spyroulias, P. Cordopatis. Enzymatic Stability, Solution Structure, and Antiproliferative Effect on Prostate Cancer Cells of Leuprolide and New GnRH Peptide Analogs. Biopolymers 96, 260-272 (2011). 10.1002/bip.21521

Jan 04

23. Conformational Dynamics of the Anthrax Lethal Factor

23. G.A. Dalkas, C. Chasaspis, P. Gkazonis, D. Bentrop, G.A. Spyroulias. Conformational Dynamics of the Anthrax Lethal Factor  catalytic center. Biochemistry 49, 10767-10769 (2010). 10.1021/bi1017792

Jan 04

22. Zinc Binding Properties of Engineered RING Finger Domain of Arkadia E3 Ubiquitin Ligase. Bioinorg. Chem. Appl. 2010, pii: 323152 (2010)

22. C.T. Chasapis, A. Loutsidou, M.G. Orkoula, G.A. Spyroulias.  Zinc Binding Properties of Engineered RING Finger Domain of Arkadia E3 Ubiquitin Ligase. Bioinorg. Chem. Appl. 2010, pii: 323152 (2010). 10.1155/2010/323152

Jan 04

21. Synthesis and Biological Evaluation of New CRH Analogues. Bioinorg. Chem. Appl. 2010, pii: 252348 (2010)

21. S. Papazacharias, V. Magafa, N. Bernad, G. Pairas, G.A. Spyroulias, J. Martinez, P. Cordopatis. Synthesis and Biological Evaluation of New CRH Analogues. Bioinorg. Chem. Appl. 2010, pii: 252348 (2010). 10.1155/2010/252348

Jan 04

20. Purification and Biophysical Characterization of the Core Protease Domain of Anthrax Lethal Factor. BBRC 396, 643-647 (2010)

20. P. Gkazonis, G.A. Dalkas, C. Chasaspis, A. Vlamis-Gardikas, D. Bentrop, G.A. Spyroulias. Purification and Biophysical Characterization of the Core Protease Domain of Anthrax Lethal Factor. BBRC 396, 643-647 (2010). 10.1016/j.bbrc.2010.04.144

Jan 04

19. Synthetic Peptides as Catalytic Site Maquettes of Angiotensin-I Converting Enzyme Catalytic Sites. Bioinorg. Chem. Appl. 2010

19. A.S. Galanis, Z. Spyranti, G. Pairas, E. Manessi-Zoupa, G.A. Spyroulias, P. Cordopatis. Synthetic Peptides as Catalytic Site Maquettes of Angiotensin-I Converting Enzyme Catalytic Sites. Bioinorg. Chem. Appl. 2010, pii: 820476 (2010). 10.1155/2010/820476

Jan 04

18. In position seven L- and D-Tic-substituted oxytocin and deamino oxytocin. NMR study and conformational speculations. Amino Acids 39, 539-548 (2010)

18. Spyranti, M. Fragiadaki, V. Magafa, L. Borovickova, G.A. Spyroulias, P. Cordopatis, J. Slaninova. In position seven L- and D-Tic-substituted oxytocin and deamino oxytocin. NMR study and conformational speculations. Amino Acids 39, 539-548 (2010). 10.1007/s00726-009-0470-1

Jan 04

17. A Computational Approach to the Study of the Binding Mode of Dual ACE / NEP Inhibitors. J. Chem. Inf. Model.

17. N. Dimitropoulos, A. Papakyriakou, G.A. Dalkas, E.D. Sturrock, G.A. Spyroulias. A Computational Approach to the Study of the Binding Mode of Dual ACE / NEP Inhibitors. J. Chem. Inf. Model. 50, 388-396 (2010). 10.1021/ci9005047

Jan 04

16. NMR Structural Elucidation of Myelin Basic Protein epitope 83-99 implicated in Multiple Sclerosis. Amino Acids 38, 929-936 (2010)

16. Z. Spyranti, T. Tselios, G. Deraos, J. Matsoukas, G.A. Spyroulias. NMR Structural Elucidation of Myelin Basic Protein epitope 83-99 implicated in Multiple Sclerosis. Amino Acids 38, 929-936 (2010). 10.1007/s00726-009-0301-4

Jul 15

15. Study of a lipophilic captopril analogue binding to Angiotensin I Converting Enzyme

15. G.A. Dalkas, D. Marchand, J.-C. Galleyrand, J. Martinez, G.A. Spyroulias, P. Cordopatis, F.Cavelier. Study of a lipophilic captopril analogue binding to Angiotensin I Converting Enzyme. J. Pept. Sci. 16, 91-97 (2010). 10.1002/psc.1201